Login / Signup

Tissue plasminogen activator in left ventricular assist device-related intravascular hemolysis after failed augmented anticoagulation.

Robert Kenneth SimsNina SrourLamees I El NihumBashar HannawiRaquel Araujo-GutierrezAna S Cruz-SolbesBarry H TrachtenbergImad HussainJu H KimMahwash KassiEdward A GravissAngelina M AlbertJerry EstepArvind BhimarajAshrith Guha
Published in: The International journal of artificial organs (2022)
Management of IVH with administration of low-dose tPA after failed AAC is feasible and may prevent pump exchange in some patients.
Keyphrases
  • low dose
  • left ventricular assist device
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • atrial fibrillation
  • venous thromboembolism
  • coronary artery
  • high dose
  • patient reported outcomes
  • drug induced